325 related articles for article (PubMed ID: 25249556)
61. Pseudogene PTENP1 Functions as a Competing Endogenous RNA (ceRNA) to Regulate PTEN Expression by Sponging miR-499-5p.
Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP
Biochemistry (Mosc); 2016 Jul; 81(7):739-47. PubMed ID: 27449620
[TBL] [Abstract][Full Text] [Related]
62. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.
Maolakuerban N; Azhati B; Tusong H; Abula A; Yasheng A; Xireyazidan A
Cancer Biol Ther; 2018 Apr; 19(4):282-291. PubMed ID: 29394133
[TBL] [Abstract][Full Text] [Related]
63. Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
Yoshino H; Yonezawa T; Yonemori M; Miyamoto K; Sakaguchi T; Sugita S; Osako Y; Tatarano S; Nakagawa M; Enokida H
Oncol Rep; 2018 Jan; 39(1):173-181. PubMed ID: 29192325
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
[TBL] [Abstract][Full Text] [Related]
65. Reduced expression of cathepsin F predicts poor prognosis in patients with clear cell renal cell carcinoma.
Zhou X; Chen H; Huang D; Guan G; Ma X; Cai W; Liao J; Guan T
Sci Rep; 2024 Jun; 14(1):13556. PubMed ID: 38866930
[TBL] [Abstract][Full Text] [Related]
66. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
[TBL] [Abstract][Full Text] [Related]
67. PTEN regulates expression of its pseudogene in glioblastoma cells in DNA methylation-dependent manner.
Kovalenko TF; Yadav B; Anufrieva KS; Larionova TD; Aksinina TE; Latyshev YA; Bastola S; Shakhparonov MI; Pandey AK; Pavlyukov MS
Biochimie; 2024 Apr; 219():74-83. PubMed ID: 37619809
[TBL] [Abstract][Full Text] [Related]
68. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
69. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
[TBL] [Abstract][Full Text] [Related]
70. [Study on expression of PTEN gene and its pseudogene PTENP1 in acute leukemia and correlation between them].
Wang CC; Huai L; Zhang CP; Jia YJ; Li QH; Chen YR; Tian Z; Tang KJ; Xing HY; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):896-901. PubMed ID: 23363743
[TBL] [Abstract][Full Text] [Related]
71. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
72. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
73. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer.
Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X
Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581
[TBL] [Abstract][Full Text] [Related]
74. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
75. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
76. Pseudogene HSPB1P1 contributes to renal cell carcinoma proliferation and metastasis by targeting miR-296-5p to regulate HMGA1 expression.
Chen Z; Wang Z; Chen Z; Fu F; Huang X; Huang Z
Cell Biol Int; 2021 Dec; 45(12):2479-2489. PubMed ID: 34431162
[TBL] [Abstract][Full Text] [Related]
77. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
78. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN.
Schneider E; Keppler R; Prawitt D; Steinwender C; Roos FC; Thüroff JW; Lausch E; Brenner W
Int J Oncol; 2011 Mar; 38(3):823-31. PubMed ID: 21206972
[TBL] [Abstract][Full Text] [Related]
79. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
[TBL] [Abstract][Full Text] [Related]
80. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]